CORE Seminar - Sept. 28 2026 - Dr. Dan Poenaru

CORE Seminar - Sept. 28 2026 - Dr. Dan Poenaru

🎙 Dr. Dan Poenaru 👥 390 📅 September 29, 2026 ⏱ 66 min 👁 31 📄 expert opinion 🧭 2026-10-08
Available in: English (current) Français

Keywords

LLM in medicineagentic AIsystematic review automationcitation fabricationadversarial review

Summary

Dr. Dan Poenaru, a pediatric surgeon and researcher at McGill, presents a seminar on the use of large language models (LLMs) in clinical research, framed as a journey from simple spell-checker-like assistance to genuine co-investigator roles. He begins with an audience poll showing that most attendees have used LLMs recently, several have used them for drafting manuscripts or grants, and many have encountered confident errors. He contrasts software engineering, where code compilation provides free verification, with medicine, where verification is costly and often constitutes the real task. He traces the evolution of LLMs from GPT-3.5 to agentic systems (late 2025–early 2026), describing how agents now autonomously plan, execute, and self-check tasks. He discusses risks: agent swarms, automation bias, deskilling (e.g., reduced adenoma detection in colonoscopy), and biosecurity concerns. He then reviews evidence on LLM performance in systematic reviews, showing high agreement with humans for screening and data extraction but weaker risk-of-bias assessment, and cites a Lancet study on citation fabrication rates (0.57% overall, higher for obscure topics). He presents multi-agent ‘virtual lab’ systems that generate research with minimal human writing. Finally, he shares his lab’s framework based on ‘friction’: low friction for ideation and literature search, high friction for data analysis and writing, and adversarial review for grants. He emphasizes that friction depends on error-detection cost and who holds the keyboard, and that human oversight remains essential.

227 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk offers substantial practical value for clinical researchers navigating LLM adoption. Its core argument is that the utility of LLMs is governed by the cost of verifying their output relative to the task’s value, a framing that is both intuitive and actionable. The speaker supports this with concrete examples: low-friction tasks like reformatting a CV or finding literature yield clear time savings, while high-friction tasks like data interpretation or manuscript writing require careful human review. He grounds his claims in published studies, such as a 2026 Journal of Clinical Epidemiology review of 63 studies on AI-assisted systematic reviews and a Journal of Evidence-Based Medicine review of 18 studies, reporting high agreement (0.98–0.99) and dramatic time reductions (500 to 5–25 hours). He also cites a Lancet 2026 analysis of 2.5 million papers and 125 million references, finding a 0.57% fabrication rate, and notes that fabrication is higher for obscure topics. The argumentation is largely coherent and self-critical: he acknowledges his own use of AI in writing, admits uncertainty about future risks, and distinguishes between his expertise and areas beyond it. However, some claims are anecdotal (e.g., his son’s interview process, agent swarms invading Australia) and lack citations, and the evidence on deskilling is referenced only generally. The overall argument is persuasive but relies on a mix of robust literature and personal observation.

Scientific Rigor, Source Quality, Title Accuracy

The speaker demonstrates scientific rigor by citing specific journals and studies, including the Journal of Clinical Epidemiology, Journal of Evidence-Based Medicine, Lancet, and JMIR. He is careful to note limitations, such as the lack of a ground truth in systematic reviews and the difficulty of attributing citation fabrication to AI versus human error. He also acknowledges that his quantitative figures are approximate and that he checked the journals he cites. However, the presentation lacks a formal reference list, and some sources are mentioned only in passing (e.g., the Lancet gastroenterology study on colonoscopy deskilling). The title, ‘From Spell Checker to Co-investigator: Working with large language models in clinical research,’ accurately reflects the content, which spans basic to advanced LLM applications in research. The talk does not overpromise; it delivers a balanced view of capabilities and risks. The absence of defined chapters means the audience must rely on the speaker’s structure, which is clear but informal.

392 words

Title / Content Match

The title accurately reflects the content: the talk moves from basic LLM use (spell-checker level) to advanced co-investigator workflows in clinical research, matching the announced topic.

Quality & Reliability

7/10

The talk is delivered by a credentialed clinician-researcher (Professor of Surgery and Pediatrics, McGill; senior scientist at RI-MUHC; associate academic member at Mila) and is grounded in his own lab's experience and in named journal literature. However, several quantitative claims are delivered from memory or paraphrased without precise citations, some dates and figures appear imprecise, and the presentation is a seminar-style expert opinion rather than a systematic review. The reliance on a small number of cited studies and on personal anecdote limits verifiability, though the speaker is transparent about uncertainty and about the limits of his own knowledge.

Key Moments

Cited Sources

  • Journal of Clinical Epidemiology 2026 study on AI in systematic reviews — Review of 63 studies using AI for systematic reviews, reporting high agreement for screening and data extraction.
  • Journal of Evidence-Based Medicine study on AI in systematic reviews — Review of 18 studies showing sensitivity/specificity of 0.98–0.99 and time savings from 500 to 5–25 hours.
  • Lancet 2026 study on citation fabrication — Analysis of 2.5 million papers and 125 million references, finding a 0.57% fabrication rate.
  • JMIR study on citation fabrication in mental health — Comparison of common vs. rare topics, showing higher fabrication for obscure topics.
  • Nature 2026 multi-agent systems publications — Three separate multi-agent systems (e.g., virtual lab, co-scientist) that automate research tasks.

Concurring Sources

  • Journal of Clinical Epidemiology 2026 study — Supports the claim that AI performs well in systematic review screening and data extraction.
  • Journal of Evidence-Based Medicine study — Corroborates high sensitivity/specificity and time savings in systematic reviews.
  • Lancet 2026 citation fabrication study — Provides quantitative evidence on the low but non-zero rate of fabricated citations.

Dissenting Sources

  • Anecdotal reports of high citation fabrication in grant reviews — The speaker's colleague reported a case where all references in a grant were fabricated, contrasting with the low 0.57% rate from the Lancet study; this suggests variability by model, prompt, or context.

Contribution & Novelties

The talk’s original contribution lies in its practical framework for integrating LLMs into clinical research, centered on the concept of ‘friction.’ Rather than debating whether to use AI, the speaker proposes calibrating human oversight based on the cost of error detection and the expertise of the user. He introduces the idea that verification cost is the key determinant of appropriate AI use, and he shares his lab’s specific practices: low friction for ideation and literature search, high friction for data analysis and writing, and adversarial review for grants. He also highlights the shift from question-answering to project-executing agents, and the emergence of multi-agent ‘virtual labs’ that produce research with minimal human writing. These insights are grounded in his lab’s experience and in recent literature, offering a nuanced, experience-based perspective that goes beyond generic AI hype or doom.

Pour aller plus loin :

188 words

Radar Profile

The radar profile shows a balanced content with moderate-to-high information quantity and quality, reflecting a well-structured seminar with concrete examples and literature references. Technical level is moderate, suitable for a clinical research audience, and overall reliability is solid given the speaker's expertise and transparency about limitations. The profile indicates a practical, experience-based talk rather than a deep technical or systematic review.

Reliability 7/10